Amarin Corp Plc (AMRN)

[ziploc_1]

Rose...QUOTE... "Heck if we simply look at statins, even amongst those that feel that they offer great benefit, no one, I believe, would say that they offer IMMEDIATE protection from CVD events"

Statins are already accepted as SOC(standard of care) through out the world...That is why a fixed dose combo with EPA and a statin would be more credible to Docs and patients as a way to reduce CVD....

At this time, most patients and many Docs have still never heard of Vascepa...but they have heard of statins....When they see a combo Rx for 'Vastatin', they won't have to ask..."what is this drug treating?"

After losing patent protection for V, this is a strategy, Amarin could have immediately turned to, knowing that competition for V from generics was coming soon.